tetano
Editor, Senior Moderator
Enferm Infecc Microbiol Clin. 2019 May;37 Suppl 1:47-55. doi: 10.1016/S0213-005X(19)30182-X.
[h=1]Diagnostic challenges in influenza.[/h] [Article in English, Spanish]
Ortiz de Lejarazu Leonardo R[SUP]1[/SUP], Rojo Rello S[SUP]2[/SUP], Sanz Mu?oz I[SUP]3[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] In 2018 there are still microbiology laboratories that do not subtype or detect influenza viruses, one of the main agents of community-acquired pneumonia. A major challenge is to introduce multiplex-type technologies into most clinical virological diagnostic laboratories, increasing the feasibility of timely etiological diagnosis of influenza and other respiratory viruses whenever required and thus limiting antibiotic treatments. Other diagnostic tools such as markers of severity and the detection of resistance are pending challenges to complete and expand. Viral culture, an essential tool in the epidemiological surveillance of viruses, has been relegated by more sensitive and affordable molecular techniques. Sequencing of the influenza virus together with the antigenic characterisation and detection techniques of antibodies against hemagglutinin and neuraminidase will, in future, be used in tandem with other techniques to detect antibodies against other structural proteins, helping to elucidate the complicated epidemiology of these viruses and the production of new vaccines and their evaluation. Supplement information: This article is part of a supplement entitled ?SEIMC External Quality Control Programme. Year 2016?, which is sponsored by Roche, Vircell Microbiologists, Abbott Molecular and Francisco Soria Melguizo, S.A. ? 2019 Elsevier Espa?a, S.L.U. and Sociedad Espa?ola de Enfermedades Infecciosasy Microbiolog?a Cl?nica. All rights reserved.
Copyright ? 2019 Elsevier Espa?a, S.L.U. All rights reserved.
[h=4]KEYWORDS:[/h] CONSISE; Diagn?stico de gripe; Epidemiological surveillance; Influenza diagnosis; Influenza virus; Neuraminidasa; Neuraminidase; Seroepidemiology; Seroepidemiolog?a; Vigilancia epidemiol?gica; Virus de la gripe
PMID: 31138423 DOI: 10.1016/S0213-005X(19)30182-X
[h=1]Diagnostic challenges in influenza.[/h] [Article in English, Spanish]
Ortiz de Lejarazu Leonardo R[SUP]1[/SUP], Rojo Rello S[SUP]2[/SUP], Sanz Mu?oz I[SUP]3[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] In 2018 there are still microbiology laboratories that do not subtype or detect influenza viruses, one of the main agents of community-acquired pneumonia. A major challenge is to introduce multiplex-type technologies into most clinical virological diagnostic laboratories, increasing the feasibility of timely etiological diagnosis of influenza and other respiratory viruses whenever required and thus limiting antibiotic treatments. Other diagnostic tools such as markers of severity and the detection of resistance are pending challenges to complete and expand. Viral culture, an essential tool in the epidemiological surveillance of viruses, has been relegated by more sensitive and affordable molecular techniques. Sequencing of the influenza virus together with the antigenic characterisation and detection techniques of antibodies against hemagglutinin and neuraminidase will, in future, be used in tandem with other techniques to detect antibodies against other structural proteins, helping to elucidate the complicated epidemiology of these viruses and the production of new vaccines and their evaluation. Supplement information: This article is part of a supplement entitled ?SEIMC External Quality Control Programme. Year 2016?, which is sponsored by Roche, Vircell Microbiologists, Abbott Molecular and Francisco Soria Melguizo, S.A. ? 2019 Elsevier Espa?a, S.L.U. and Sociedad Espa?ola de Enfermedades Infecciosasy Microbiolog?a Cl?nica. All rights reserved.
Copyright ? 2019 Elsevier Espa?a, S.L.U. All rights reserved.
[h=4]KEYWORDS:[/h] CONSISE; Diagn?stico de gripe; Epidemiological surveillance; Influenza diagnosis; Influenza virus; Neuraminidasa; Neuraminidase; Seroepidemiology; Seroepidemiolog?a; Vigilancia epidemiol?gica; Virus de la gripe
PMID: 31138423 DOI: 10.1016/S0213-005X(19)30182-X